We will have limited operations from 15:00 Wednesday 24 December 2025 (AEDT) until Friday 2 January 2026. Find out how to contact us during the holiday period.
OFEV, VARGATEF (Boehringer Ingelheim Pty Ltd)
Product name
OFEV, VARGATEF
Sponsor
Date registered
Evaluation commenced
Decision date
Approval time
223 (255 working days)
Active ingredients
nintedanib esilate
Registration type
EOI
Indication
OFEV, VARGATEF (soft capsule) are now also indicated for the treatment of other chronic fibrosing Interstitial Lung Diseases (ILDs) with a progressive phenotype.